MOSCOW, May 30. /TASS/. Russia’s Rosatom State Atomic Energy Corporation is ready to invest in projects in the countries where it is allowed by legislation, Director General Sergei Kiriyenko said Monday.
"We are ready in the countries where it is allowed to be investors though we do not claim the controlling stake," he said.
Russia and Kenya are in talks over what may become Kenya’s first-ever nuclear power plant construction project, as follows from the Atomexpo-2017 memorandum of understanding concluded by Russia’s state nuclear power corporation Rosatom and Kenya’s Nuclear Electricity Board, a TASS correspondent reports from the site of the event.
The memorandum lays the basis for likely cooperation in designing, building and operating commercial and research nuclear power reactors.
Russia and Kenya are to create a working group for identifying joint projects for the creation of Kenya’s own nuclear power industry.
According to the memorandum the consultations over plans for building a nuclear power plant in Kenya and Rosatom’s likely participation in it will be continued. Talks are due soon on the conclusion of an inter-governmental agreement.
Russia and Nigeria have inked an intergovernmental agreement on cooperation in the construction of a nuclear research and technologies center in Nigeria, a TASS correspondent reported on Monday from the signing ceremony.
The document was signed by Director General of Russia’s state-run nuclear corporation Rosatom, Sergei Kiriyenko, and Director General of Nigeria’s Atomic Energy Commission, Erepano Osaisai, on the sidelines of the Atomexpo-2016 international forum.
The agreement envisages the construction of a nuclear research center on the basis of a multi-purpose pool-type water-cooled research reactor of the Russian design with a capacity of up to ten megawatt at the Sheda Nuclear Technology Center in Abuja.
The would-be center will make it possible for Nigeria to use nuclear technologies in science, medicine, agriculture and other areas. It will turn out isotopes that will be used in diagnosis and treatment of cancer.